Gastrointestinal Molecular Diagnostics Market: By Technology, By Disease Indication, By Application, By End-users and Geography

Gastrointestinal Molecular Diagnostics Market Size, Share, Growth, Trends, and Global Industry Analysis: By Technology (Polymer Chain Reaction, Next-Generation Sequencing), By Disease Indication (Viruses, Bacteria, and Parasite), By Application (Infectious Diseases, Gastrointestinal Cancers), By End-users (Hospital & Clinics, Research Institution, and Diagnostic Laboratories) and Region

Gastrointestinal Molecular Diagnostics Market size was valued at US$ 150 million in 2023, and is poised to grow at a CAGR of 3.6% from 2024 to 2030. The gastrointestinal molecular diagnostics market is anticipated to witness significant growth in the coming years, driven by several factors, such as the rising prevalence of gastrointestinal diseases, technological advancement (next-generation sequencing and PCR), growing awareness of the benefits of molecular diagnostics, and additionally supportive government policies around the world are creating a fertile ground for the global gastrointestinal molecular diagnostics market to flourish. Which empowers doctors to pinpoint and characterize genetic mutations linked to gastrointestinal diseases with exceptional precision and sensitivity. This, coupled with the growing need for early diagnoses and personalized treatments, which driving the gastrointestinal molecular diagnostics market demand in the fight against gastrointestinal ailments.

Gastrointestinal Molecular Diagnostics Market Key Developments:
  • In June 2022, the SENTiFIT 800 analyzer, an automated system for Fecal Immunochemical tests, was launched by Sentinel Diagnostics.
  • In March 2022, the agreement between Hardy Diagnostic and Applied BioCode for the distribution of the MDx-3000 System for the diagnosis of gastrointestinal infections. 

Gastrointestinal Molecular Diagnostics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

3.6%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Gastrointestinal Molecular Diagnostics Market Dynamics

The gastrointestinal molecular diagnostics market is expected to continue its growth trajectory in the coming years, driven by the increasing burden of gastrointestinal diseases according to the University of Gothenburg, in every ten adults in the world, four suffer from GIDs of varying severity, technological advancements in molecular biology techniques, such as next-generation sequencing (NGS) are leading to the development of more specific and sensitive diagnostic tests, and a growing emphasis on personalized medicine.  However, addressing challenges related to cost and regulatory hurdles will be crucial for sustained market expansion.

Gastrointestinal Molecular Diagnostics Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 150 million

Market CAGR

3.6%

By Technology

  • Polymer Chain Reaction,
  • Next-Generation Sequencing

By Disease Indication

  • Viruses,
  • Bacteria, and
  • Parasite

By Application

  • Infectious Diseases,
  • Gastrointestinal Cancers

By End User

  • Hospital & Clinics
  • Research Institution
  • Diagnostic Laboratories

Key Features of the Report

  • The gastrointestinal molecular diagnostics market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.

Download Free Sample Report

Frequently Asked Questions

The gastrointestinal molecular diagnostics market size was valued at US$ 150 million in 2023 and is poised to grow at a (CAGR) of 3.6% from 2024 to 2030.

F. Hoffmann-La Roche AG, Abbott Laboratories, Danaher Corporation (Cepheid), Hologic, bioMérieux SA, Illumina, Inc., QIAGEN, BD, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Illumina, Inc.., Grifols, S.A., Siemens Healthineers AG, and Sysmex Corporation.

Asia-Pacific is the fastest growing and North America is the dominant market in Gastrointestinal molecular diagnostics

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Gastrointestinal Molecular Diagnostics Market Introduction 
2.1.Global Gastrointestinal Molecular Diagnostics Market  - Taxonomy
2.2.Global Gastrointestinal Molecular Diagnostics Market  - Definitions
2.2.1.Type 
2.2.2.Disease Indication
2.2.3.Application
2.2.4.End User
2.2.5.Region
3.Global Gastrointestinal Molecular Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Gastrointestinal Molecular Diagnostics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Gastrointestinal Molecular Diagnostics Market  By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Polymer Chain Reaction,
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Next-Generation Sequencing
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6.Global Gastrointestinal Molecular Diagnostics Market  By Disease Indication, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Viruses,
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Bacteria, and
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Parasite
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Gastrointestinal Molecular Diagnostics Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Infectious Diseases,
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Gastrointestinal Cancers
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
8.Global Gastrointestinal Molecular Diagnostics Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Hospital & Clinics
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Research Institution
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Diagnostic Laboratories
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
9.Global Gastrointestinal Molecular Diagnostics Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Gastrointestinal Molecular Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Polymer Chain Reaction,
10.1.2.Next-Generation Sequencing
10.2.  Disease Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Viruses,
10.2.2.Bacteria, and
10.2.3.Parasite
10.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Infectious Diseases,
10.3.2.Gastrointestinal Cancers
10.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Hospital & Clinics
10.4.2.Research Institution
10.4.3.Diagnostic Laboratories
10.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Gastrointestinal Molecular Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Polymer Chain Reaction,
11.1.2.Next-Generation Sequencing
11.2.  Disease Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Viruses,
11.2.2.Bacteria, and
11.2.3.Parasite
11.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Infectious Diseases,
11.3.2.Gastrointestinal Cancers
11.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Hospital & Clinics
11.4.2.Research Institution
11.4.3.Diagnostic Laboratories
11.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
12.Asia Pacific (APAC) Gastrointestinal Molecular Diagnostics Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Polymer Chain Reaction,
12.1.2.Next-Generation Sequencing
12.2.  Disease Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Viruses,
12.2.2.Bacteria, and
12.2.3.Parasite
12.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Infectious Diseases,
12.3.2.Gastrointestinal Cancers
12.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Hospital & Clinics
12.4.2.Research Institution
12.4.3.Diagnostic Laboratories
12.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Gastrointestinal Molecular Diagnostics Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Polymer Chain Reaction,
13.1.2.Next-Generation Sequencing
13.2.  Disease Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Viruses,
13.2.2.Bacteria, and
13.2.3.Parasite
13.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Infectious Diseases,
13.3.2.Gastrointestinal Cancers
13.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Hospital & Clinics
13.4.2.Research Institution
13.4.3.Diagnostic Laboratories
13.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Gastrointestinal Molecular Diagnostics Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Polymer Chain Reaction,
14.1.2.Next-Generation Sequencing
14.2.  Disease Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Viruses,
14.2.2.Bacteria, and
14.2.3.Parasite
14.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Infectious Diseases,
14.3.2.Gastrointestinal Cancers
14.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Hospital & Clinics
14.4.2.Research Institution
14.4.3.Diagnostic Laboratories
14.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Hoffmann-La Roche AG
15.2.2.Abbott Laboratories
15.2.3.Danaher Corporation (Cepheid)
15.2.4.Hologic, Inc.
15.2.5.bioMérieux SA
15.2.6.Illumina, Inc.
15.2.7.QIAGEN
15.2.8.BD
15.2.9.Bio-Rad Laboratories, Inc.
15.2.10.Agilent Technologies, Inc.
15.2.11.Illumina, Inc.
15.2.12.Grifols, S.A.
15.2.13.Siemens Healthineers AG
15.2.14.Sysmex Corporation
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • Hoffmann-La Roche AG
  • Abbott Laboratories
  • Danaher Corporation (Cepheid)
  • Hologic, Inc.
  • bioMérieux SA
  • Illumina, Inc.
  • QIAGEN
  • BD
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Grifols, S.A.
  • Siemens Healthineers AG
  • Sysmex Corporation

Related Industry Reports